PhD Scholar of Regional Cancer Centre, India
Mrs. Shanaz Sharaf is a dedicated researcher with 7 years of experience in biotechnology, biomedical sciences, cell and molecular biology, and clinical research. 🎓 Her work primarily focuses on understanding prognostic tumor markers in Triple Negative Breast Cancer (TNBC), exploring molecular and cell signaling aspects in tumorigenesis, and developing innovative technologies for cancer detection. 🧬 Passionate about advancing cancer research, Mrs. Sharaf is committed to creating novel multiplex technologies for tumor tissue imaging. She aims to leverage her skills and knowledge in a collaborative environment to contribute to cutting-edge scientific advancements and gain exposure to emerging technologies. 🌟
Professional profile
Education📚
Mrs. Shanaz Sharaf holds a Doctor of Philosophy (Ph.D.) in Biotechnology from Manipal Academy of Higher Education, India, where she conducted research on prognostic markers and multiplex platforms for breast cancer classification. 📚 Her academic journey includes a Master of Science in Biotechnology from the University of Kerala, graduating with first-class honors and a distinction of 75.05%. 🎓 Prior to that, she earned a Bachelor of Science in Botany and Biotechnology from the University of Kerala, also with first-class honors and a notable 74.05%. 🌟 Her educational background equips her with a strong foundation in biotechnological and biomedical sciences, essential for her research endeavors.
Professional Experience🏛️
Mrs. Shanaz Sharaf brings a wealth of experience to her field, having served as a PhD Scholar at the Regional Cancer Centre, Thiruvananthapuram, Kerala, India, from 2019 to 2024. 🎓 Her research focused on identifying prognostic markers and developing multiplex platforms for breast cancer classification under the guidance of Dr. K Sujathan. 🧬 Prior to her PhD, she worked as a Junior Research Fellow on translational research in Triple Negative Breast Cancer (2017-2019) and investigated maternal sleep deprivation effects on offspring cognition (2014-2015) at SCTIMST, Thiruvananthapuram. 🔬 Her extensive research background showcases her expertise in molecular and cell biology, particularly in cancer research and innovative diagnostic techniques. 🧪
Research Interest🌐
Mrs. Shanaz Sharaf’s research interests lie in the intersection of biotechnology and cancer research. 🔬 Her primary focus is on understanding the role of prognostic tumor markers in Triple Negative Breast Cancer (TNBC), aiming to enhance disease outcome predictions and improve detection methods. 🧬 She explores various molecular and cell signaling pathways involved in tumorigenesis and is passionate about developing novel multiplex technologies for tumor tissue imaging. 🧪 Her work seeks to innovate cancer detection and treatment, leveraging cutting-edge techniques to advance the field of oncology. 🌟
Awards and Honors🏆
Mrs. Shanaz Sharaf has received notable recognition for her contributions to cancer research and biotechnology. 🏅 Her commitment to advancing the field has been acknowledged through various awards and honors. 🎖️ These accolades highlight her innovative work and dedication, reflecting her impact on the scientific community and her role in pioneering new approaches to cancer detection and treatment. 🌟 Her achievements underscore her excellence and commitment to improving health outcomes through research and innovation. 🌺
Achievements🏅
- 🎓 Doctoral Research: Completed a Ph.D. in Biotechnology at Manipal Academy of Higher Education, focusing on identifying prognostic markers and developing multiplex platforms for breast cancer classification.
- 🧬 Research Contributions: Significant work in Triple Negative Breast Cancer, including translational research and novel strategies in cancer detection.
- 🔬 Conference Organization: Actively involved in organizing major conferences like the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research (2019) and the National Conference on ETHB (2023).
- 📚 Research Experience: Junior Research Fellow (JRF) with projects on maternal sleep deprivation effects and translational research in breast cancer.
- 🏆 Professional Recognition: Contributed to significant research advancements and gained recognition within the scientific community for her innovative approaches and findings.
- 💡 Innovative Technologies: Development of innovative multiplex technologies for tumor tissue imaging, enhancing cancer research methodologies.
Projects🛠️
- 🔍 Prognostic Markers in Breast Cancer: Identified a panel of prognostic markers and developed a multiplex platform for histoclinical classification of breast cancer during her Ph.D. research at the Regional Cancer Centre.
- 🧬 Triple Negative Breast Cancer: Conducted translational research focusing on the role of various prognostic tumor markers in Triple Negative Breast Cancer.
- 🧪 Maternal Sleep Deprivation Study: Investigated the effects of maternal sleep deprivation on cognition in offspring using an animal model during her tenure as a Junior Research Fellow.
- 🧩 Tumor Tissue Imaging: Worked on developing innovative multiplex technologies for enhanced imaging of tumor tissues.
- 🗂️ Conference Organization: Played a key role in organizing major conferences, including the Indo-Swedish Conference on Analytical Cell Biology and Machine Learning in Cancer Research and the National Conference on ETHB.
Publications top noted📜
- 📄 “Subcellular expression of MTA1, HIF1A, and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study”
- Authors: Sharaf, S.S., Jaganath Krishna, K.M., Lekshmi, A., Sujathan
- Journal: Journal of Molecular Histology
- Year: 2024
- Volume: 55
- Issue: 3
- Pages: 303–315
- Citations: 0
- 📄 “A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor – Quantum dot conjugates and a panel of chromogenic dyes”
- Authors: Sharaf, S.S., Lekshmi, A., S, A., Santhosh Kumar, T.R., K, S.
- Journal: Pathology Research and Practice
- Year: 2024
- Volume: 253
- Article: 155033
- Citations: 1
